741P Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI) + 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone.
Hubner, Richard A Chen, L Li, C Bodoky, G Dean, A Lee, K Cunningham, D Siveke, J Braiteh, F de Jong, F
Hubner, Richard A
Chen, L
Li, C
Bodoky, G
Dean, A
Lee, K
Cunningham, D
Siveke, J
Braiteh, F
de Jong, F
Citations
Altmetric:
Abstract
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
741P Prognostic value of baseline neutrophil-to-lymphocyte ratio for predicting clinical outcome in metastatic pancreatic ductal adenocarcinoma (mPDAC) patients treated with liposomal irinotecan (nal-IRI) + 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone. 2017, 28(suppl_5): Ann Oncol